Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · see citing works

Functional Bowel Disorders

Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856 · see citing works

Functional Gastroduodenal Disorders

Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418 · see citing works

An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome

American College of Gastroenterology IBS Task Force (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.122 · Cited by 694 · see citing works

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders 1 1This study was registered with ClinicalTrials.gov (trial registry no. NCT00006157).

Drossman, D. A., Toner, B. B., Whitehead, W. E., Diamant, N. E., Dalton, C. B., Duncan, S., Emmott, S., Proffitt, V., Akman, D., Frusciante, K., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00669-3 · Cited by 614 · see citing works

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582 · see citing works

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

Creed, F., Fernandes, L., Guthrie, E., Palmer, S., Ratcliffe, J., Read, N., Rigby, C., Thompson, D., & Tomenson, B. (2003) · Gastroenterology · doi:10.1053/gast.2003.50055 · Cited by 443 · see citing works

Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome

Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389 · see citing works

How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis

Mills, E. J., Ioannidis, J. P. A., Thorlund, K., Schünemann, H. J., Puhan, M. A., & Guyatt, G. H. (2012) · JAMA · doi:10.1001/2012.jama.11228 · Cited by 361 · see citing works

Peripheral mechanisms in irritable bowel syndrome

Camilleri, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1207068 · Cited by 300 · see citing works

Efficacy of Buspirone, a Fundus-Relaxing Drug, in Patients With Functional Dyspepsia

Tack, J. F., Janssen, P., Masaoka, T., Farré, R., & Oudenhove, L. V. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.06.036 · Cited by 289 · see citing works

A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome

Tack, J. F., Broekaert, D., Fischler, B., Oudenhove, L. V., Gevers, A. M., & Janssens, J. (2006) · Gut · doi:10.1136/gut.2005.077503 · Cited by 289 · see citing works

Peripheral Mechanisms in Irritable Bowel Syndrome

Kassam, Z., Collins, S. M., & Moayyedi, P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1214185 · Cited by 285 · see citing works

Multicenter, Randomized, Placebo-Controlled Trial of Amitriptyline in Children With Functional Gastrointestinal Disorders

Saps, M., Youssef, N. N., Miranda, A., Nurko, S., Hyman, P. E., Cocjin, J. T., & Lorenzo, C. D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.060 · Cited by 253 · see citing works

An Evidence-Based Systematic Review on the Management of Irritable Bowel Syndrome

Brandt, L. J., Chey, W. D., Foxx-Orenstein, A. E., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P. S., Spiegel, B. M., Talley, N. J., & Moayyedi, P. (2009) · American Journal of Gastroenterology · doi:10.14309/00000434-200901001-00002 · Cited by 225 · see citing works

SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication

Bouras, E. P., Delgado-Aros, S., Camilleri, M., Castillo, E. J., Burton, D. D., Thomforde, G. M., & Chial, H. J. (2002) · Gut · doi:10.1136/gut.51.6.781 · Cited by 218 · see citing works

Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome

GORARD, D. A., LIBBY, G. W., & FARTHING, M. J. G. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00273.x · Cited by 211 · see citing works

The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled study

Kuiken, S. D., Tytgat, G. N. J., & Boeckxstaens, G. E. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)70039-1 · Cited by 206 · see citing works

Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain

Bomholt, S. F., Mikkelsen, J. D., & Blackburn-Munro, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.012 · Cited by 204 · see citing works

Paroxetine to Treat Irritable Bowel Syndrome Not Responding to High-Fiber Diet: A Double-Blind, Placebo-Controlled Trial

Tabas, G., Beaves, M., Wang, J., Friday, P., Mardini, H. E., & Arnold, G. L. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04127.x · Cited by 192 · see citing works

The effect of fluoxetine in patients with pain and constipation‐predominant irritable bowel syndrome: a double‐blind randomized‐controlled study

Vahedi, H., Merat, S., RASHIDIOON, A., Ghoddoosi, A. R., & Malekzadeh, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02566.x · Cited by 181 · see citing works

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

Chial, H., Camilleri, M., Burton, D., Thomforde, G., Olden, K., & Stephens, D. (2003) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00266.2002 · Cited by 169 · see citing works

Clinical trial: the effect of amitriptyline in patients with diarrhoea‐predominant irritable bowel syndrome

Vahedi, H., Merat, S., Momtahen, S., Kazzazi, A., GHAFFARI, N., Olfati, G., & Malekzadeh, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03633.x · Cited by 155 · see citing works

Efficacy of tricyclic antidepressants in irritable bowel syndrome: A meta-analysis

Rahimi, R., Nikfar, S., Rezaie, A. R., & Abdollahi, M. R. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1548 · Cited by 155 · see citing works

The Need for Large-Scale Randomized Evidence Without Undue Emphasis on Small Trials, Meta-analyses, or Subgroup Analyses

Hennekens, C. H. (2009) · JAMA · doi:10.1001/jama.2009.1756 · Cited by 149 · see citing works

Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial

van Kerkhoven, L. A. S., LAHEIJ, R., Aparicio, N., Boer, W. A. D., van den Hazel, S. J., TAN, A., Witteman, B. J. M., & Jansen, J. B. �. �. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.051 · Cited by 141 · see citing works

Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled Trial

Talley, N. J., Kellow, J. E., Boyce, P. M., Tennant, C., Huskic, S., & Jones, M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9830-4 · Cited by 130 · see citing works

5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake.

Gorard, S. A. C., Libby, G., & Farthing, M. J. G. (1994) · Gut · doi:10.1136/gut.35.4.496 · Cited by 107 · see citing works

Influence of buspirone on gastric sensorimotor function in man

Oudenhove, L. V., Kindt, S., Vos, R., Coulie, B., & Tack, J. (2008) · Alimentary Pharmacology and Therapeutics · doi:10.1111/j.1365-2036.2008.03849.x · Cited by 87 · see citing works

Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention

Fukudo, S., Kanazawa, M., Mizuno, T., Hamaguchi, T., Kano, M., Watanabe, S., Sagami, Y., Shoji, T., Endo, Y., Hongo, M., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.083 · Cited by 84 · see citing works

Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans

Chial, H. J., Camilleri, M., Ferber, I. J., Delgado-Aros, S., Burton, D. D., McKinzie, S., & Zinsmeister, A. R. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)70038-x · Cited by 84 · see citing works

A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome

Masand, P. S., Pae, C., Krulewicz, S., Peindl, K., Mannelli, P., Varia, I. M., & Patkar, A. A. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.1.78 · Cited by 82 · see citing works

Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man

Tack, J. F., Broekaert, D., Corsetti, M., Fischler, B., & Janssens, J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02724.x · Cited by 73 · see citing works

Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study

Braak, B., Klooker, T. K., Wouters, M. M., Lei, A., van den Wijngaard, R. M., & Boeckxstaens, G. E. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04775.x · Cited by 72 · see citing works

New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline

Otaka, M., Jin, M., Odashima, M., Matsuhashi, T., Wada, I., Horikawa, Y., Komatsu, K., Ohba, R., Oyaké, J., Hatakeyama, N., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02473.x · Cited by 71 · see citing works

Candidate genes and sensory functions in health and irritable bowel syndrome.

Camilleri, M., Busciglio, I., Carlson, P., Mckinzie, S., Burton, D., Baxter, K., Ryks, M., & Zinsmeister, A. (2008) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90202.2008 · Cited by 68 · see citing works

Mechanisms in IBS: something old, something new, something borrowed…

Camilleri, M. (2005) · Neurogastroenterology and Motility · doi:10.1111/j.1365-2982.2004.00632.x · Cited by 61 · see citing works

Effects of Amitriptyline on Gastric Sensorimotor Function and Postprandial Symptoms in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial

Bouras, E. P., Talley, N. J., Camilleri, M., Burton, D. D., Heckman, M. G., Crook, J. E., & Richelson, E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02021.x · Cited by 60 · see citing works

Performance characteristics of the measurement of gastric volume using single photon emission computed tomography

Breen, M. A., Camilleri, M., Burton, D. D., & Zinsmeister, A. R. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01660.x · Cited by 58 · see citing works

Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression

Friedrich, M., Grady, S. E., & Wall, G. C. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.07.002 · Cited by 48 · see citing works

Functional Dyspepsia Treatment Trial (FDTT): A double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics

Talley, N. J., Locke, G. R., Herrick, L. M., Silvernail, V. M., Prather, C. M., Lacy, B. E., DiBaise, J. K., Howden, C. W., Brenner, D. M., Bouras, E. P., et al. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.02.002 · Cited by 38 · see citing works

Does a Preexisting Anxiety Disorder Predict Response to Paroxetine in Irritable Bowel Syndrome?

Masand, P. S., Gupta, S., Schwartz, T. L., Kaplan, D. S., Virk, S., Hameed, A., & Lockwood, K. (2002) · Psychosomatics · doi:10.1176/appi.psy.43.6.451 · Cited by 19 · see citing works

Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans

Chial, H. J., Camilleri, M., Ferber, I. J., Delgado-Aros, S., McKinzie, S., Burton, D. D., & Zinsmeister, A. R. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)81112-5 · Cited by 6 · see citing works

Biopsychosocial Aspects of Functional Gastrointestinal Disorders: How Central and Environmental Processes Contribute to the Development and Expression of Functional Gastrointestinal Disorders

Van Oudenhove, L., Levy, R. L., Crowell, M. D., Drossman, D. A., Halpert, A. D., Keefer, L., Lackner, J. M., Murphy, T. B., & Naliboff, B. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.027 · Cited by 512 · see citing works

The role of inflammation in irritable bowel syndrome (IBS)

Ng, Q. X., Soh, A. Y. S., Loke, W., Lim, D. Y., & Yeo, W. S. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s174982 · Cited by 360 · see citing works

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

Barnes, N. M., Ahern, G. P., Bécamel, C., Bockaert, J., Camilleri, M., Chaumont‐Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C. F., Gershon, M. D., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 264 · see citing works

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS)

Moayyedi, P., Andrews, C., MacQueen, G., Korownyk, C., Marsiglio, M., Graff, L., Kvern, B., Lazarescu, A., Liu, L. W. C., Paterson, W., et al. (2019) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwy071 · Cited by 182 · see citing works

Evidence for Neuronal and Structural Changes in Submucous Ganglia of Patients With Functional Dyspepsia

Cirillo, C., Bessissow, T., Desmet, A.-S., Vanheel, H., Tack, J. F., & Berghe, P. V. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.158 · Cited by 159 · see citing works

Drug–gut microbiota interactions: implications for neuropharmacology

Walsh, J., Griffin, B. T., Clarke, G. A., & Hyland, N. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14366 · Cited by 150 · see citing works

Opioid misuse in gastroenterology and non-opioid management of abdominal pain

Szigethy, E., Knisely, M., & Drossman, D. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.141 · Cited by 117 · see citing works

Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management

Gros, M., Gros, B., Mesonero, J. E., & Latorre, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153429 · Cited by 117 · see citing works

Functional Dyspepsia: Diagnostic and Therapeutic Approaches

Sayuk, G. S., & Gyawali, C. P. (2020) · Drugs · doi:10.1007/s40265-020-01362-4 · Cited by 110 · see citing works

A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS)

Ng, Q. X., Soh, A. Y. S., Loke, W., Venkatanarayanan, N., Lim, D. Y., & Yeo, W. S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100298 · Cited by 95 · see citing works

Gastroduodenal Mechanisms Underlying Functional Gastric Disorders

Carbone, F., & Tack, J. F. (2014) · Digestive Diseases · doi:10.1159/000357854 · Cited by 79 · see citing works

Hypermobile Ehlers–Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know

Thwaites, P. A., Gibson, P. R., & Burgell, R. E. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15927 · Cited by 59 · see citing works

Evidence for PMAT- and OCT-like biogenic amine transporters in a probiotic strain of Lactobacillus: Implications for interkingdom communication within the microbiota-gut-brain axis

Lyte, M., & Brown, D. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191037 · Cited by 60 · see citing works

Treatment of abdominal pain in irritable bowel syndrome

Vanuytsel, T., Tack, J. F., & Boeckxstaens, G. E. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0966-7 · Cited by 51 · see citing works

Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial

Fukudo, S., Nakamura, M., Hamatani, T., Kazumori, K., & Miwa, H. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.03.019 · Cited by 42 · see citing works

Irritable Bowel Syndrome: Modern Concepts and Management Options

Sayuk, G. S., & Gyawali, C. P. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.01.036 · Cited by 50 · see citing works

The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders

Ringel, Y. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.014 · Cited by 39 · see citing works

Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review

Browne, P., Nagelkerke, S., van Etten-Jamaludin, F. V., Benninga, M., & Tabbers, M. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1540298 · Cited by 32 · see citing works

Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia

Rosen, J. M. (2014) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v5.i3.122 · Cited by 35 · see citing works

Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: A meta-analysis

Zareifopoulos, N., & Dylja, I. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.01.016 · Cited by 26 · see citing works

Metabolic Kinetics of 5-Hydroxytryptamine and the Research Targets of Functional Gastrointestinal Disorders

Jing, F.-C., & Zhang, J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3244-x · Cited by 23 · see citing works

Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety

Lan, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i32.11422 · Cited by 24 · see citing works

Acotiamide improves stress‐induced impaired gastric accommodation

Ikeo, K., Oshima, T., Sei, H., Kondo, T., Fukui, H., Watari, J., & Miwa, H. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12991 · Cited by 21 · see citing works

Potential rat model of anxiety-like gastric hypersensitivity induced by sequential stress

Fu-chun, J., Zhang, J., Feng, C., Nian, Y., Wang, J., Hu, H., Baode, Y., Sun, X.-M., Zheng, J., & Yin, X. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i42.7594 · Cited by 21 · see citing works

Faecal microbiota transplantation alleviates symptoms of depression in individuals with irritable bowel syndrome: A case series

Collyer, R., Clancy, A., & Borody, T. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100029 · Cited by 19 · see citing works

Clinical Predictors of Rapid Gastric Emptying in Patients Presenting with Dyspeptic Symptoms

Cifuentes, J. D. G., Radetic, M., López, R., & Gabbard, S. L. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05620-8 · Cited by 21 · see citing works

Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review

Oh, S. J., Takakura, W., & Rezaie, A. R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092933 · Cited by 17 · see citing works

Capsaicin: A Novel Approach to the Treatment of Functional Dyspepsia

Liu, T., Wan, Y., Meng, Y., Zhou, Q., Li, B., Chen, Y., & Wang, L. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200793 · Cited by 16 · see citing works

Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus

Chen, D.-Y., Jia, L., Gu, X. J., Jiang, S.-M., Xie, H., & Xu, J. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.05.025 · Cited by 16 · see citing works

Pilot trial: Pregabalin on colonic sensorimotor functions in irritable bowel syndrome

Iturrino, J., Camilleri, M., Busciglio, I. A., Burton, D. D., & Zinsmeister, A. R. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.09.002 · Cited by 14 · see citing works

Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients

Yan, X.-J., Li, W., Chen, X., Wang, E.-M., Liu, Q., Qiu, H.-Y., Cao, Z., & Chen, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i15.4652 · Cited by 14 · see citing works

The effect of sildenafil on gastric motility and satiation in healthy controls

Carbone, F., & Tack, J. F. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618766933 · Cited by 14 · see citing works

Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome

Stănculete, M. F., Dumitrascu, D. L., & Drossman, D. A. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-4090 · Cited by 14 · see citing works

Alternative splicing in serotonergic system: Implications in neuropsychiatric disorders

Latorre, E., Mesonero, J. E., & Harries, L. W. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119856546 · Cited by 13 · see citing works

Affective dysfunction mediates the link between neuroimmune markers and the default mode network functional connectivity, and the somatic symptoms in somatic symptom disorder

Park, B., Lee, S., Jang, Y., & Park, H. Y. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.017 · Cited by 12 · see citing works

Predictive factors of inadequate bowel preparation for elective colonoscopy.

Sadeghi, A., Rajabnia, M., Bagheri, M., Jamshidizadeh, S., Saberi, S., Shahnazi, P., Pasharavesh, L., Pourhoseingholi, M. A., Mirzaei, M., Aghdaei, H. A., et al. (2022) · Gastroenterology and hepatology from bed to bench. · Cited by 12 · see citing works

Cannabidiol and Intestinal Motility: a Systematic Review

Story, G., Briere, C., McClements, D. J., & Sela, D. A. (2023) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2023.101972 · Cited by 11 · see citing works

Comprehensive Treatment of Functional Dyspepsia Using Traditional Chinese Medicine: A Review Based on Pathophysiological Perspectives

Fan, M., Pan, X., & Liu, Y. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s514042 · Cited by 12 · see citing works

Serotonin Transporter Gene (SLC6A4) Polymorphism May Be Associated with Chinese Globus Pharyngeus and Its Antidepressant Effects

Liu, Y., Jia, L., Jiang, S.-M., Chen, D.-Y., Song, J.-S., & Xu, J. (2018) · Digestion · doi:10.1159/000484202 · Cited by 10 · see citing works

The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study

Wade, U., Pascual-Figal, D. A., Rabbani, F., Ernst, M., Albert, A., Janssens, I., Dierckxsens, Y., Iqtadar, S., Khokhar, N. A., Kanwal, A., et al. (2024) · Nutrients · doi:10.3390/nu16081204 · Cited by 10 · see citing works

The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut

Brown, K. J., Funk, K., Barrientos, A. F., Bailey, A., Shrader, S. H., Feng, W., McClain, C. J., & Song, Z. (2024) · Cells · doi:10.3390/cells13191618 · Cited by 9 · see citing works

Treatment of Functional Dyspepsia and Gastroparesis

Stein, B. N., Everhart, K. K., & Lacy, B. E. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0028-5 · Cited by 8 · see citing works

Functional diseases of the gastrointestinal tract in the context with overlapping functional disorders: current status of the problem

Osadchuk, M. A., Svistunov, A. А., Kireeva, N. V., & Osadchuk, M. M. (2020) · Terapevticheskii arkhiv · doi:10.26442/00403660.2020.02.000458 · Cited by 7 · see citing works

Efficacy and Safety of High Specific Volume Polysaccharide—A New Type of Dietary Fiber for Treatment of Functional Constipation and IBS-C

Liang, C. O. N. G., Jing-Ting, M. A., Jin, Z., Duan, L., Wei-Ping, S. U., Zheng, J. J., ZHANG, L.-J., Xu, J. X., & Li, D. (2015) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.61.326 · Cited by 6 · see citing works

Comparison of the Effect of Duloxetine and Imipramine in the Treatment of Patients with Diarrhea Dominant Irritable Bowel Syndrome

Jafari, S., Mahani, S. K., & Mohsen-Pour, N. (2024) · Nāmah-ʼi Dāniškadah-ʼi piziškī-i Irān. · doi:10.61186/jambr.32.150.33 · Cited by 5 · see citing works

Thorough QT/QTc Study Shows That a Novel 5‐HT4 Receptor Partial Agonist Minesapride Has No Effect on QT Prolongation

Hamatani, T., Noda, N., Takagaki, T., Yodo, Y., Kawai, H., Kakuyama, H., Kaji, Y., & Fujio, Y. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.778 · Cited by 5 · see citing works

Gastric Motor Functions in Patients With Mood Disorders and Functional Gastroduodenal Symptoms

Maselli, D. B., Park, S., & Camilleri, M. (2020) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000891 · Cited by 5 · see citing works

Forensic Botany and Stomach Contents Analysis: Established Practice and Innovation

Miller, J. A. (2017) · doi:10.1002/9781118953358.ch14 · Cited by 5 · see citing works

Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches

Torres-Maravilla, E., Carvalho, F. A., Holowacz, S., Delannoy, J., Lenoir, L., Jacouton, E., Barbut, F., Langella, P., Bermúdez‐Humarán, L. G., & Waligora‐Dupriet, A. (2024) · Beneficial Microbes · doi:10.1163/18762891-bja00006 · Cited by 5 · see citing works

The Effect of Ondansetron on Improvement of Symptoms in Patients with Irritable Bowel Syndrome with Diarrhea Domination: A Randomized Controlled Trial

Jafari, S., Atmani, A., Gohari, S., & Seifi, E. (2024) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2024.386 · Cited by 4 · see citing works

Walker‐256 tumor alters morphology of intestinal myenteric plexus in rats

Marega, P., Liberti, E. A., Freitas, J. S., & Kietzer, K. (2018) · Neurogastroenterology and Motility · doi:10.1111/nmo.13322 · Cited by 6 · see citing works

Comparison of fluoxetine and duloxetine hydrochloride therapeutic effects on patients with constipation-predominant irritable bowel syndrome.

Jafari, S., Sajedi, B., Jameshorani, M., & Salarpour, F. (2022) · Gastroenterology and hepatology from bed to bench. · Cited by 3 · see citing works

Azapirones for the treatment of anxiety - an overview

Knap, B., Kwiatkowski, S., Kolasińska, K., Knap-Czop, K., Przystupski, D., Roguzińska, S., & Kędzierska, E. (2018) · World Scientific News · Cited by 2 · see citing works

Management of Overlap Syndrome between Functional Dyspepsia and Irritable Bowel Syndrome by Western and Traditional Chinese Medicine

Chen, F. (2017) · Yangtze Medicine · doi:10.4236/ym.2017.12012 · Cited by 2 · see citing works

Cell fitness is an omniphenotypePreprint

Jacobs, N. C., Park, J., Saccone, N. L., & Peterson, T. R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/487157 · Cited by 2 · see citing works

Recomendaciones de buena práctica clínica para el uso de neuromoduladores en gastroenterología: revisión conjunta de expertos de la Asociación Mexicana de Gastroenterología (AMG) y Asociación Mexicana de Neurogastroenterología y Motilidad (AMNM)

Gomez-Escudero, O., Remes-Troche, J. M., Coss-Adame, E., García‐Zermeño, K. R., Aquino-Matus, J. E., Pavón, J. J., Valdovinos-García, L. R., Vargas-Martínez, M. A., Amieva‐Balmori, M., Arenas-Martinez, J. S., et al. (2025) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2024.12.001 · Cited by 4 · see citing works

A Pilot Analysis of Bioparameters in Patients with Dyspepsia Accompanied by Abdominal Hardness: An Exploration of Damjeok Syndrome Rooted in Traditional Medicine

Lim, Y.-S., Son, C., Lee, J.-H., Yang, S., Park, D., Rho, G.-H., Choi, G.-H., & Choi, S.-H. (2025) · Healthcare · doi:10.3390/healthcare13182307 · Cited by 1 · see citing works

Current and novel therapeutic strategies in pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified

Vermeijden, N. K., Oorthuys, A., Groen, J., Thapar, N., Vlieger, A., Puoti, M. G., Borrelli, O., & Benninga, M. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2582017 · Cited by 1 · see citing works

Effect of Amitriptyline in Patients with Functional Dyspepsia

Jo, Y. (2015) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2015.66.4.245 · Cited by 1 · see citing works

Chronic Idiopathic Nausea

Kovacic, K. K., & Chelimsky, G. G. (2014) · Pediatric Annals · doi:10.3928/00904481-20140325-10 · Cited by 1 · see citing works

Migraine Comorbidities

Godley, F. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-50376-9_9 · Cited by 1 · see citing works

Pain in irritable bowel syndrome

Zielińska, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821324-7.00010-1 · Cited by 1 · see citing works

Progress in research of low-grade inflammation in irritable bowel syndrome

Chi, Z.-C. (2022) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v30.i24.1051

Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociación Mexicana de Gastroenterología) - AMNM (Asociación Mexicana de Neurogastroenterología y Motilidad) expert joint review

Gomez-Escudero, O., Remes-Troche, J. M., Coss-Adame, E., García‐Zermeño, K. R., Aquino-Matus, J. E., Pavón, J. J., Valdovinos-García, L. R., Vargas-Martínez, M. A., Amieva‐Balmori, M., Arenas-Martinez, J. S., et al. (2025) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2024.12.001

Association Between Venlafaxine Exposure And Treatment Outcomes In Older Adults With Depression: Association entre l’exposition à la venlafaxine et les résultats du traitement chez les personnes âgées atteintes de dépression

Men, X., Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Stefan, C., Ramsey, L. B., Lenze, E. J., Reynolds, C. F., et al. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437261451057

Treating functional gastrointestinal disorders with antidepressants

Gorard, D. A., Libby, G., & Farthing, M. J. G. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00383-1 · Cited by 7 · see citing works

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health.

Chial, H., Camilleri, M., Burton, D., Thomforde, G., Olden, K., & Stephens, D. (2003) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00266.2002 · Cited by 169 · see citing works

Review: antidepressive agents improve symptoms and reduce pain in patients with functional gastrointestinal disorders

Calam, J. (2000) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.5.4.115

The Use of Antidepressants in Functional Gastrointestinal Disorders: New Uses for Old Drugs

Olden, K. W. (2005) · CNS Spectrums · doi:10.1017/s1092852900019866 · Cited by 48 · see citing works

Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia?

Oudenhove, L. V., & Tack, J. F. (2008) · Nature Clinical Practice Gastroenterology &#38 Hepatology · doi:10.1038/ncpgasthep1334 · Cited by 18 · see citing works